Cooperative Agreement to the Medical Research Council (MRC) of South Africa for TB Control and HIV Prevention, Care, and Treatment Activities (U51)

The summary for the Cooperative Agreement to the Medical Research Council (MRC) of South Africa for TB Control and HIV Prevention, Care, and Treatment Activities (U51) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Cooperative Agreement to the Medical Research Council (MRC) of South Africa for TB Control and HIV Prevention, Care, and Treatment Activities (U51)
	CFDA Number:	93.116
	CFDA Description:	Project Grants and Cooperative Agreements for Tuberculosis Control Programs
	Federal Agency Name:	Centers for Disease Control and Prevention
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-PS-07-006
	Document Type:	Modification to Previous Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Mar 05, 2007
	Creation Date:	Mar 19, 2007
	Original Closing Date for Applications:	Apr 03, 2007 Applications must be received by 5 p.m. on the application deadine date.
	Current Closing Date for Applications:	Information not provided
	Archive Date:	May 03, 2007
	Expected Number of Awards:	1
	Estimated Total Program Funding:	$5,000,000
	Federal Grant Award Ceiling:	$5,000,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Application for this program is limited to that organization previously funded under Program Announcement Number 02032: The MRC of South Africa for TB Control Activities. This limited eligibility is based on the key objectives of the program to develop and implement TB and HIV Controls, and allow the organization to carry out multiple, ongoing public-health research activities in South Africa. MRC is the only qualified agency that has the technical and administrative capacity to conduct the specific set of activities requested to support CDC TB and HIV activities in South Africa under this cooperative agreement because: 1) MRC is uniquely positioned, in terms of legal authority, ability, track record, and credibility in South Africa to develop and support control activities in both public and non-governmental organization sites through the country; 2) MRC has already established a framework and mechanism to develop and implement TB and HIV treatment and control activities in South Africa, enabling it to immediately become engaged in the activities listed in this announcement; 3) MRC has been mandated by the South African government to coordinate and implement TB treatment and control activities including MDR-TB and TB/HIV co-infection within the country; 4) MRC has a unique and unparalleled relationship with the Department of Health (DOH), national Tuberculosis Control Program (NTP) and HIV program and the South African National Tuberculosis Association (SANTA) based on a long history of collaboration; 5) MRC coordinates the research and development activities for the Global Alliance for TB Drug Development in the search for a better, more effective and affordable cure for TB that is shorter, equally effective against susceptible and drug-resistant TB, and accessible to the populations that need it most. HHS/CDC/NCHHSTP/DTBE entered into a cooperative agreement with the MRC in 2002 to help support and ensure implementation of TB control activities that are designed to develop, establish, and coordinate systems and procedures to address the obstacles to achieving control of TB and MDR-TB in South Africa. This cooperative agreement was supplemented in FY06 with PEPFAR funding to implement additional TB/HIV related activities
Grant Description: . NCHSTP announces the availability of fiscal year (FY) 2007 funds for a cooperative agreement to support and ensure the implementation of tuberculosis (TB) control and HIV prevention, care, and treatment activities in South Africa. These activities are designed to develop, establish, and coordinate systems and procedures to address the obstacles to achieving control of TB, multidrug-resistant tuberculosis (MDR-TB), and extensively drug-resistant tuberculosis (XDR-TB) in South Africa as well as improve prevention, care, and treatment of HIV. These collaborative activities can profoundly improve the diagnostic and treatment capacity for MDR-TB by the South African National TB Control Program, as well as improve TB treatment and control programs and HIV prevention, care, and treatment efforts in South Africa.
Link to Full Grant Announcement: RFA-PS-07-006
http://www.cdc.gov/od/pgo/funding/FOAs.htm
Grant Announcement Contact: PGOTIM
Phone 770-488-2700 pgotim@cdc.gov CDC Procurements and Grants Office
Similar Government Grants: • Tuberculosis Elimination and Laboratory Cooperative Agreements; • International Union Against Tuberculosis and Lung Disease (IUATLD): Improving the Effectiveness of T...; • TB Elimination and Laboratory; • Tuberculosis Elimination and Laboratory Cooperative Agreements